deltatrials
Active Not Recruiting NA INTERVENTIONAL 1-arm NCT06202274

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Sponsor: Candela Corporation

Conditions Acne Benign Cutaneous Vascular Lesions Hair Reduction Scars Skin Conditions Tattoo Removal Wrinkle
Interventions Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE
Updated 5 times since 2024 Last updated: Aug 18, 2025 Started: Oct 4, 2023 Primary completion: Oct 4, 2028 Completion: Oct 4, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06202274, this NA trial focuses on Acne and Benign Cutaneous Vascular Lesions and remains ongoing. Sponsored by Candela Corporation, it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotRecruiting~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshotRecruiting~Sep 2025 – present · 10 months · monthly snapshotActive Not Recruiting

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  2. Mar 2025 — Sep 2025 [monthly]

    Recruiting NA

  3. Sep 2024 — Mar 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Feb 2024 — Jul 2024 [monthly]

    Recruiting NA

    First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Candela Corporation
Data source: Candela Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations